©2017 by Microtest Diagnostics.

Microtest Matrices Limited (in Administration)



Ken Touhey of IRL, Chatsworth House, 39 Chatsworth Road, Worthing, West Sussex, BN11 1LY was appointed administrator of Microtest Matrices Limited to manage its affairs, business and property as its agent and acts without personal liability.


Ken Touhey is licensed in the United Kingdom to act as insolvency practitioner by the Institute of Chartered Accountants in England and Wales.


The  administrator is bound by the Insolvency Code of Ethics which can be found at: https://www.gov.uk/government/publications/insolvency-practitioner-code-of-ethics.


The administrator is a  Data Controller of personal data as defined by the Data Protection Act 1998. IRL will act as a Data Processor on the Administrator’s instructions. Personal data will be kept secure and processed only for matters relating to the administration.


The quality of allergens used in allergy testing matters greatly. To optimize the performance of its allergens Microtest set up an allergy development laboratory
 in Uppsala, Sweden and hired experts in allergen preparation. The laboratory prepares whole allergen extracts and highly purified components, and, with investment could be capable of producing allergen components by recombinant methods.

Clinical Value

Independent clinical trials have indicated the value of adopting the Microtest platform:

Microtest results are comparable to those of standard singleplex tests currently cited as the gold standard for IgE testing

Testing for multiple IgE sensitizations is particularly helpful in the management of patients with IgE-mediated asthma

Microarray testing is more useful than standard extract-based diagnostic methods in the evaluation of children with multiple allergic sensitizations, which often complicates persistent childhood asthma. Highly reliable allergy testing is crucial for optimal care of these children.

A new kind of allergy testing

Microtest has developed a testing regime based on a microarray: a collection of microscopic spots of allergens attached to a solid surface. The allergens used in the microarray can be customised for clinician preference and for the patient’s location.  

The level of sensitisation can be used together with other clinical information to determine the likelihood that an allergic reaction is attributable to a specific allergen.

Microtest Diagnostics

Microtest is a UK-based company focused on diagnostic testing

that helps clinicians manage patients’ allergies more effectively.


Microtest offers a new kind of allergy testing.  Instead of testing against allergens one by one to find those causing the problem(s), which is how most allergy testing is undertaken, Microtest offers a quick, accurate and convenient snapshot of a person’s state of sensitization, i.e., reaction, to many allergens (a panel) at the same time. It does this in vitro by carrying out testing of Immunoglobulin E (IgEs) on patient blood samples.


Microtest addresses a range of allergens, including respiratory and food.